Back to Results
First PageMeta Content
Aliskiren / Health / Renin inhibitor / Endocrinology / Antihypertensive drug / ACE inhibitor / Angiotensin II receptor antagonist / Angiotensin-converting enzyme / European Medicines Agency / Peptide hormones / Biology / Medicine


Aliskiren Q&A and interim recommendation
Add to Reading List

Document Date: 2013-07-21 06:25:34


Open Document

File Size: 65,30 KB

Share Result on Facebook

City

London / /

Company

Novartis Europharm Ltd. / /

Country

Estonia / Romania / United Kingdom / Lithuania / Latvia / /

/

Facility

Canary Wharf / /

IndustryTerm

healthcare professionals / study site / /

MedicalCondition

low blood pressure / hypertension / disease / particularly involved stroke / high blood pressure / essential hypertension / cardiovascular disease / diabetes / hypotension / /

Organization

Committee for Medicinal Products for Human Use / European Union / Data Monitoring Committee / European Medicines Agency / E-mail info@ema.europa.eu Website www.ema.europa.eu An / European Commission / /

/

Position

pharmacist / /

URL

www.ema.europa.eu/Find / www.ema.europa.eu / /

SocialTag